Patrik Jonsson, the president of Lilly Bio-Medicines
Who knew? Dermira’s board kept watch as its stock price tracked Eli Lilly’s secret bidding on a $1.1B buyout
In just 8 days, from December 6 to December 14, the stock jumped from $7.88 to $12.70 — just under the initial $13 bid. There was no hard news about the company that would explain a rise like that tracking closely to the bid offer, raising the obvious question of whether insider info has leaked out to traders.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
